Loss-of-function mutation in DDX53 associated with hereditary spastic paraplegia-like disorder
- PMID: 38753040
- DOI: 10.1007/s00109-024-02454-4
Loss-of-function mutation in DDX53 associated with hereditary spastic paraplegia-like disorder
Abstract
DEAD-box helicase 53 (DDX53) is a member of the DEAD-box protein family of RNA helicases. Unlike other family members that are responsible for RNA metabolism, the biological function of DDX53 and its impact on the human condition are unclear. Herein, we found a full-length DDX53 deletion mutation in a hereditary spastic paraplegia-like (HSP-like) patient with lower extremity spasticity, walking disorder, visual impairment, and lateral ventricular white matter lesions. Bioinformatic analysis revealed that DDX53 was mainly expressed in the cerebellar cortex and may function as a tissue-specific RNA helicase. Transcriptome analysis showed that the expression of multiple brain-associated genes involved in synapse organization, neuron function, and neuromuscular junctions was affected by DDX53 depletion. Moreover, RNA immunoprecipitation sequencing (RIP-seq) analysis showed that DDX53 interacted with 176 genes, and 96 of these genes were associated with the execution of neurofunction, particularly in the regulation of cell projection organization and nervous system development. Collectively, although a more specified cell or animal model is required to fully understand the functional role of DDX53 in the human brain, we report for the first time that the patient with DDX53 defects exhibits HSP-like symptoms and that DDX53 is essential for maintaining neuronal function, with loss-of-function mutation in DDX53 potentially leading to HSP due to impaired RNA metabolism in the nervous system. KEY MESSAGES: DDX53 deficiency was first reported to be associated with HSP disorder. DDX53 exhibited minimal impact on mitochondrial function. DDX53 impaired RNA metabolism in the nervous system.
Keywords: DDX53; HSP-like disorder; Loss-of-function mutation; RNA metabolism.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
A novel SPAST gene mutation identified in a Chinese family with hereditary spastic paraplegia.BMC Med Genet. 2020 Jun 3;21(1):123. doi: 10.1186/s12881-020-01053-7. BMC Med Genet. 2020. PMID: 32493220 Free PMC article.
-
NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup.BMC Med Genet. 2017 Mar 21;18(1):33. doi: 10.1186/s12881-017-0395-6. BMC Med Genet. 2017. PMID: 28327087 Free PMC article.
-
Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).Brain. 2017 Feb;140(2):287-305. doi: 10.1093/brain/aww307. Brain. 2017. PMID: 28137957 Free PMC article.
-
A novel homozygous mutation in ERLIN1 gene causing spastic paraplegia 62 and literature review.Eur J Med Genet. 2022 Nov;65(11):104608. doi: 10.1016/j.ejmg.2022.104608. Epub 2022 Sep 12. Eur J Med Genet. 2022. PMID: 36100157 Review.
-
Two novel homozygous mutations of CAPN1 in Chinese patients with hereditary spastic paraplegia and literatures review.Orphanet J Rare Dis. 2019 Apr 25;14(1):83. doi: 10.1186/s13023-019-1053-1. Orphanet J Rare Dis. 2019. PMID: 31023339 Free PMC article. Review.
References
-
- Hedera P (2021) Hereditary spastic paraplegia overview. GeneReviews® [Internet] (Bookshelf ID: NBK1509)
Publication types
MeSH terms
Substances
Grants and funding
- 82222043/National Natural Science Foundation of China-excellent young scientists fund
- 2024C03152/the Pioneer and Leading Goose Research and Development Program of Zhejiang Province
- 82172322/Natural Science Foundation of China
- 82302636/the Natural Science Foundation of China
- Q23H200001/Zhejiang Provincial Natural Science Foundation
LinkOut - more resources
Full Text Sources
Miscellaneous